These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 26648662

  • 41. HIV-positive-to-HIV-positive kidney transplantation.
    Fulco PP.
    N Engl J Med; 2015 May 21; 372(21):2069-70. PubMed ID: 25992755
    [No Abstract] [Full Text] [Related]

  • 42. HIV-positive-to-HIV-positive kidney transplantation.
    Ho YH, Lu K.
    N Engl J Med; 2015 May 21; 372(21):2070. PubMed ID: 25992756
    [No Abstract] [Full Text] [Related]

  • 43. [Nitrated esters of polyalcohols in cardiovascular therapy].
    BALATRE P, MERLEN J, GRANDJEAN L.
    Presse Med (1893); 1949 Nov 19; 57(73):1067-9. PubMed ID: 15397756
    [No Abstract] [Full Text] [Related]

  • 44. Non-oxidative Modified Low-density Lipoproteins: The Underappreciated Risk Factors for Atherosclerosis.
    Zhao Y, Xu Q, He N, Jiang M, Chen Y, Ren Z, Tang Z, Wu C, Liu L.
    Curr Med Chem; 2024 Nov 19; 31(34):5598-5611. PubMed ID: 37550912
    [Abstract] [Full Text] [Related]

  • 45. Nitrotyrosine, Nitrated Lipoproteins, and Cardiovascular Dysfunction in Patients with Type 2 Diabetes: What Do We Know and What Remains to Be Explained?
    Jakubiak GK, Cieślar G, Stanek A.
    Antioxidants (Basel); 2022 Apr 27; 11(5):. PubMed ID: 35624720
    [Abstract] [Full Text] [Related]

  • 46. Lipoproteins and fatty acids in chronic kidney disease: molecular and metabolic alterations.
    Noels H, Lehrke M, Vanholder R, Jankowski J.
    Nat Rev Nephrol; 2021 Aug 27; 17(8):528-542. PubMed ID: 33972752
    [Abstract] [Full Text] [Related]

  • 47. Role of Myeloperoxidase in Patients with Chronic Kidney Disease.
    Kisic B, Miric D, Dragojevic I, Rasic J, Popovic L.
    Oxid Med Cell Longev; 2016 Aug 27; 2016():1069743. PubMed ID: 27127544
    [Abstract] [Full Text] [Related]

  • 48. Plasma Nitration of High-Density and Low-Density Lipoproteins in Chronic Kidney Disease Patients Receiving Kidney Transplants.
    Bakillah A, Tedla F, Ayoub I, John D, Norin AJ, Hussain MM, Brown C.
    Mediators Inflamm; 2015 Aug 27; 2015():352356. PubMed ID: 26648662
    [Abstract] [Full Text] [Related]

  • 49. Myeloperoxidase-mediated oxidation targets serum apolipoprotein A-I in diabetic patients and represents a potential mechanism leading to impaired anti-apoptotic activity of high density lipoprotein.
    Lu N, Xie S, Li J, Tian R, Peng YY.
    Clin Chim Acta; 2015 Feb 20; 441():163-70. PubMed ID: 25528002
    [Abstract] [Full Text] [Related]

  • 50. Very low density lipoprotein metabolism and plasma adiponectin as predictors of high-density lipoprotein apolipoprotein A-I kinetics in obese and nonobese men.
    Chan DC, Barrett PH, Ooi EM, Ji J, Chan DT, Watts GF.
    J Clin Endocrinol Metab; 2009 Mar 20; 94(3):989-97. PubMed ID: 19116237
    [Abstract] [Full Text] [Related]

  • 51. Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes.
    Welty FK, Lichtenstein AH, Barrett PH, Dolnikowski GG, Schaefer EJ.
    Arterioscler Thromb Vasc Biol; 2004 Sep 20; 24(9):1703-7. PubMed ID: 15242863
    [Abstract] [Full Text] [Related]

  • 52. The apoB/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy--a review of the evidence.
    Walldius G, Jungner I.
    J Intern Med; 2006 May 20; 259(5):493-519. PubMed ID: 16629855
    [Abstract] [Full Text] [Related]

  • 53. Plasma Nitration of High-Density and Low-Density Lipoproteins in Chronic Kidney Disease Patients Receiving Kidney Transplants.
    Bakillah A, Tedla F, Ayoub I, John D, Norin AJ, Hussain MM, Brown C.
    Mediators Inflamm; 2015 May 20; 2015():352356. PubMed ID: 26648662
    [Abstract] [Full Text] [Related]

  • 54. Myeloperoxidase-mediated oxidation targets serum apolipoprotein A-I in diabetic patients and represents a potential mechanism leading to impaired anti-apoptotic activity of high density lipoprotein.
    Lu N, Xie S, Li J, Tian R, Peng YY.
    Clin Chim Acta; 2015 Feb 20; 441():163-70. PubMed ID: 25528002
    [Abstract] [Full Text] [Related]

  • 55. Very low density lipoprotein metabolism and plasma adiponectin as predictors of high-density lipoprotein apolipoprotein A-I kinetics in obese and nonobese men.
    Chan DC, Barrett PH, Ooi EM, Ji J, Chan DT, Watts GF.
    J Clin Endocrinol Metab; 2009 Mar 20; 94(3):989-97. PubMed ID: 19116237
    [Abstract] [Full Text] [Related]

  • 56. Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes.
    Welty FK, Lichtenstein AH, Barrett PH, Dolnikowski GG, Schaefer EJ.
    Arterioscler Thromb Vasc Biol; 2004 Sep 20; 24(9):1703-7. PubMed ID: 15242863
    [Abstract] [Full Text] [Related]

  • 57. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.
    Ribas V, Sánchez-Quesada JL, Antón R, Camacho M, Julve J, Escolà-Gil JC, Vila L, Ordóñez-Llanos J, Blanco-Vaca F.
    Circ Res; 2004 Oct 15; 95(8):789-97. PubMed ID: 15388641
    [Abstract] [Full Text] [Related]

  • 58. Dysfunctional high-density lipoproteins in children with chronic kidney disease.
    Kaseda R, Jabs K, Hunley TE, Jones D, Bian A, Allen RM, Vickers KC, Yancey PG, Linton MF, Fazio S, Kon V.
    Metabolism; 2015 Feb 15; 64(2):263-73. PubMed ID: 25467845
    [Abstract] [Full Text] [Related]

  • 59. Myeloperoxidase deficiency ameliorates progression of chronic kidney disease in mice.
    Lehners A, Lange S, Niemann G, Rosendahl A, Meyer-Schwesinger C, Oh J, Stahl R, Ehmke H, Benndorf R, Klinke A, Baldus S, Wenzel UO.
    Am J Physiol Renal Physiol; 2014 Aug 15; 307(4):F407-17. PubMed ID: 24990898
    [Abstract] [Full Text] [Related]

  • 60. Impaired cholesterol efflux capacity and vasculoprotective function of high-density lipoprotein in heart transplant recipients.
    Singh N, Jacobs F, Rader DJ, Vanhaecke J, Van Cleemput J, De Geest B.
    J Heart Lung Transplant; 2014 May 15; 33(5):499-506. PubMed ID: 24630408
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.